Dr Patel on the Evolving Use of Neoadjuvant PD-1 Inhibitors in CSCC
Vishal Patel, MD, FAAD, FACMS, discusses the evolving use of neoadjuvant and adjuvant PD-1 inhibition in cutaneous squamous cell carcinoma.
Source: onclive.com
Cutaneous Oncology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cutaneous Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cutaneous Oncology Program Today - Breaking & Trending Today
New cell-based immunotherapy offered for melanoma - The Source - Washington University in St. Louis
Physicians at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, will be among the first in the nation to administer a new cell-based immunotherapy to eligible patients with melanoma.
Source: wustl.edu
Pioneering cell-based treatment for melanoma offered at Siteman Cancer Center
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Source: news-medical.net
New cell-based immunotherapy offered for melanoma
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offe
Source: newswise.com
New cell-based immunotherapy offered for melanoma
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offe
Source: newswise.com